Skip to search.
 TSX Up0.07% TSX Ventures 0.00%

More On AZN.L

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


AstraZeneca PLC (AZN.L)

-LSE

3,428.00 Up 1.50(0.04%) May 24, 11:35AM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period Ending2009-12-302008-12-302007-12-302006-12-30
Total Revenue 32,804,000   31,601,000   29,559,000   26,475,000  
Cost of Revenue5,587,000  6,078,000  6,004,000  5,559,000  
Gross Profit 27,217,000   25,523,000   23,555,000   20,916,000  
Operating Expenses
Research Development -   -   -   -  
Selling General and Administrative -   -   -   -  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses19,817,000  20,914,000  20,335,000  18,718,000  
Operating Income or Loss 12,987,000   10,687,000   9,224,000   7,757,000  
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -   -  
Earnings Before Interest And Taxes12,987,000  10,687,000  9,224,000  7,757,000  
Interest Expense(560,000)(714,000)(522,000)(72,000)
Income Before Tax -   -   -   -  
Income Tax Expense3,263,000  2,551,000  2,356,000  2,480,000  
Minority Interest(23,000)(29,000)(32,000)(20,000)
Net Income From Continuing Ops7,521,000  6,101,000  5,595,000  6,043,000  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 7,521,000   6,101,000   5,595,000   6,043,000  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares -   -   -   -  

Currency in GBp.